Next Article in Journal
Metabolomic Profiling of Plasma from Melioidosis Patients Using UHPLC-QTOF MS Reveals Novel Biomarkers for Diagnosis
Next Article in Special Issue
Overexpression of TRPV3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer
Previous Article in Journal
Roles of RNA-Binding Proteins in DNA Damage Response
Previous Article in Special Issue
Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma
Open AccessArticle

Tamoxifen Treatment of Breast Cancer Cells: Impact on Hedgehog/GLI1 Signaling

1
Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge 14183, Sweden
2
Doctoral Program in Biomedical Sciences, Universidad del Rosario, Bogotá 11001000, Colombia
3
Faculty of Natural Sciences and Mathematics, Universidad del Rosario, Bogotá 11001000, Colombia
4
Department of Medical Sciences, University of Turin, Via Santena 7, 10126 Turin, Italy
5
Institute for Cancer Research and Treatment (IRCC), Strada Provinciale 142, 10060 Candiolo, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: William Chi-shing Cho
Int. J. Mol. Sci. 2016, 17(3), 308; https://doi.org/10.3390/ijms17030308
Received: 31 December 2015 / Revised: 17 February 2016 / Accepted: 22 February 2016 / Published: 27 February 2016
(This article belongs to the Collection Advances in Molecular Oncology)
The selective estrogen receptor (ER) modulator tamoxifen (TAM) has become the standard therapy for the treatment of ER+ breast cancer patients. Despite the obvious benefits of TAM, a proportion of patients acquire resistance to treatment, and this is a significant clinical problem. Consequently, the identification of possible mechanisms involved in TAM-resistance should help the development of new therapeutic targets. In this study, we present in vitro data using a panel of different breast cancer cell lines and demonstrate the modulatory effect of TAM on cellular proliferation and expression of Hedgehog signaling components, including the terminal effector of the pathway, the transcription factor GLI1. A variable pattern of expression following TAM administration was observed, reflecting the distinctive properties of the ER+ and ER− cell lines analyzed. Remarkably, the TAM-induced increase in the proliferation of the ER+ ZR-75-1 and BT474 cells parallels a sustained upregulation of GLI1 expression and its translocation to the nucleus. These findings, implicating a TAM-GLI1 signaling cross-talk, could ultimately be exploited not only as a means for novel prognostication markers but also in efforts to effectively target breast cancer subtypes. View Full-Text
Keywords: GLI1; TAM resistance; breast cancer; Hedgehog signaling; cellular proliferation GLI1; TAM resistance; breast cancer; Hedgehog signaling; cellular proliferation
Show Figures

Figure 1

MDPI and ACS Style

Villegas, V.E.; Rondón-Lagos, M.; Annaratone, L.; Castellano, I.; Grismaldo, A.; Sapino, A.; Zaphiropoulos, P.G. Tamoxifen Treatment of Breast Cancer Cells: Impact on Hedgehog/GLI1 Signaling. Int. J. Mol. Sci. 2016, 17, 308.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop